Hot List: Gogo Inc (NASDAQ:GOGO), United Therapeutics Corporation (NASDAQ:UTHR), AT&T Inc. (NYSE:T), HomeAway (NASDAQ:AWAY)

Gogo Inc (NASDAQ:GOGO), shares fell 14 percent in after-hours trading following the announcement of the new service, expected by late 2015. It will use an AT&T 4G LTE network and Honeywell systems and hardware to supply broadband service to business, commercial and general aviation passengers, as well as to airlines seeking more connectivity onboard planes.  Gogo Inc (NASDAQ:GOGO), shares after opening at $18.25  moved to $18.45 on last trade day and at the end of the day closed at $18.38. Company price to sales ratio in past twelve months was calculated as 4.76 and price to cash ratio as 5.87. Gogo Inc (NASDAQ:GOGO), showed a  negative  weekly performance of 3.82%.

On April 29, 2014, United Therapeutics Corporation (NASDAQ:UTHR), announced its financial results for the first quarter ended March 31, 2014. United Therapeutics Corporation (NASDAQ:UTHR), shares fell 2.06%   in last trading session and ended the day on $89.00.  United Therapeutics Corporation (NASDAQ:UTHR), return on equity ratio is recorded as 14.00% and its return on assets is 9.30%. United Therapeutics Corporation (NASDAQ:UTHR), yearly performance is 43.09%.

AT&T Inc. (NYSE:T), and Honeywell International Inc are teaming up to offer high-speed, in-flight Internet in the United States, the companies said on Monday, challenging industry leader Gogo Inc. AT&T Inc. (NYSE:T), shares moved up 1.71%  in last trading session and was closed at $35.08, while trading in range of $ 34.56 – 35.15. AT&T Inc. (NYSE:T), year to date (YTD) performance is 2.42%.

HomeAway, Inc. (NASDAQ:AWAY), have started the year with a bang by posting results better than market expectations. The company has shown a sharp growth of 33% in its revenue from 2013 levels. HomeAway, Inc. (NASDAQ:AWAY), weekly performance is -8.79%. On last trading day company shares ended up $32.60. HomeAway, Inc. (NASDAQ:AWAY), distance from 50-day simple moving average (SMA50) is -19.76%. Analysts mean target Price for the company is $44.38.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *